M Steven Paul

Affiliations

  • at Rapport Therapeutics Inc. (RAPP), 2025-06-18
  • at Karuna Therapeutics Inc. (KRTX), 2024-03-18
  • at Sage Therapeutics Inc. (SAGE), 2024-01-04
  • Director at Alnylam Pharmaceuticals Inc. (ALNY), 2022-04-05
  • Director at Voyager Therapeutics Inc. (VYGR), 2021-06-04
  • Director at Sigma Aldrich Corp (SIAL), 2015-11-19
  • Evp, Science And Technology at Lilly Eli & Co (LLY), 2010-02-03
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
KRTX $106.10 1,181 $125,304.10 108,849 2021-08-18 Filing
KRTX $105.63 1,183 $124,960.29 107,668 2021-08-17 Filing
KRTX $23.43 3,200 $74,976.00 10,000 2019-06-28 Filing
KRTX $22.86 6,800 $155,448.00 6,800 2019-06-28 Filing
VYGR $14.07 10,000 $140,690.00 872,351 2016-01-14 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ALNY $178.60 175 $31,255.00 1,000 2022-04-01 Filing
ALNY $177.58 825 $146,503.50 1,175 2022-04-01 Filing
ALNY $176.51 526 $92,844.26 2,000 2022-04-01 Filing
ALNY $174.33 90 $15,689.70 2,526 2022-04-01 Filing
ALNY $173.06 642 $111,104.52 2,616 2022-04-01 Filing